BMS-191011

CAS No. 202821-81-6

BMS-191011 ( BMS-A )

Catalog No. M20837 CAS No. 202821-81-6

BMS-191011 is an activator of large-conductance calcium-activated potassium (BKCa) channels effective in stroke models.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 46 In Stock
10MG 71 In Stock
25MG 147 In Stock
50MG 277 In Stock
100MG 417 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    BMS-191011
  • Note
    Research use only not for human use.
  • Brief Description
    BMS-191011 is an activator of large-conductance calcium-activated potassium (BKCa) channels effective in stroke models.
  • Description
    BMS-191011 is an activator of large-conductance calcium-activated potassium (BKCa) channels effective in stroke models.
  • Synonyms
    BMS-A
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    Potassium Channel
  • Recptor
    Potassium Channel
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    202821-81-6
  • Formula Weight
    370.71
  • Molecular Formula
    C16H10ClF3N2O3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:125 mg/mL (337.19 mM)
  • SMILES
    O=c1oc(-c2ccc(C(F)(F)F)cc2)nn1Cc1cc(Cl)ccc1O
  • Chemical Name
    134-Oxadiazol-2(3H)-one 3-((5-chloro-2-hydroxyphenyl)methyl)-5-(4-(trifluoromethyl)phenyl)-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Mori A Suzuki S Sakamoto K et al. BMS-191011 an Opener of Large-Conductance Ca2+-Activated Potassium Channels Dilates Rat Retinal Arterioles in Vivo[J]. Biological & Pharmaceutical Bulletin 2011 34(1):150-152.
molnova catalog
related products
  • Flupirtine maleate

    A selective neuronal potassium channel (KCNQ/KV7 channel) activator that also has indirect NMDA receptor antagonist and GABAA receptor modulatory properties.

  • VU0071063

    VU0071063 is a Kir6.2/SUR1 activator.

  • Gliclazide

    Gliclazide is a whole-cell beta-cell ATP-sensitive potassium currents blocker with an IC50 of 184 nM.